Ozempic Is In Short Supply. Here’s How That Affects Diabetics
Forbes Healthcare
AUGUST 25, 2024
Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to its drug maker Novo Nordisk.
Let's personalize your content